Harry Christodoulou, liver cancer participant: I was told a had roughly six to 12 months to live, then I saw Dr Peter Grimison and was compatible with a trial chemotherapy drug.
Tom McNamara, cancer trial participant: “I have worked in a hospital all my life. I know the value of having someone for testing. I was prepared to be in the control group, and I knew that it could either save my life or I would die. This wasn’t about grasping at straws to stay alive – by doing this, I was able to do something much bigger for other people as well.
Ann White, cancer trial participant: The trial has been great. The best thing about it is that I’m still alive! The trial has given me a chance to find something that works for me, and that I hope will also be of help to others...
Richard Aarden, cancer gene trial participant: I am a part of something that is contributing not only to my wellbeing but others in my situation. It’s a very positive feeling.
Simon, Ted and Matthew Frost, diabetes trial participants: Encouraging my boys to participate was not only about their own health, but the potential to make a contribution to the worldwide search for a cure to this chronic disease.
Robyn Ward, Professor, Prince of Wales Hospital: I have seen how clinical trials can change our health care, and how they help people … We have seen the cure rates for kids’ cancer go from less than 10 per cent to over 80 per cent.
Nora Straznicky,Senior Research Officer, Baker IDI Heart & Diabetes Institute: Ultimately, health care practice is based on knowledge derived from clinical trials.
Michael Good, Professor, Principal Research Leader, Institute for Glycomics, Griffith University: People get involved because they want to be part of a project that will make a difference.
Sarah Tremethick, Research Manager, Baker IDI Heart & Diabetes Institute: Clinical trials are about teamwork and patients are an integral part of the team working together to improve scientific knowledge, treatment options and clinical outcomes.
Industry and Sponsors
Mitch Kirkman, Development QA Manager, Novartis Pharmaceuticals Australia Pty Ltd: Australia has been a key contributor in the development of cutting edge new medicines in a huge range of therapeutic areas for Novartis.
Catherine Bourgeois, St Jude Medical: Australia has the clinical trial infrastructure that allows a trial to be established very quickly.